BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29936977)

  • 21. Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival.
    Yadav S; Yadav D; Zakalik D
    Breast Cancer Res Treat; 2017 Jul; 164(1):201-208. PubMed ID: 28432512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
    Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
    Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
    Sopik V; Iqbal J; Sun P; Narod SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
    Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
    Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base.
    Jacob JD; Hodge C; Franko J; Pezzi CM; Goldman CD; Klimberg VS
    J Surg Oncol; 2016 Jun; 113(7):721-5. PubMed ID: 27040042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.
    Stecklein SR; Shen X; Mitchell MP
    Clin Breast Cancer; 2016 Aug; 16(4):319-26. PubMed ID: 26943990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The implications of neighborhood socioeconomic status on surgical management and mortality in malignant phyllodes patients in the Surveillance, Epidemiology, and End Results program.
    Obeng-Gyasi S; Bhattacharyya O; Li Y; Eskander M; Tsung A; Oppong B
    Surgery; 2020 Dec; 168(6):1122-1127. PubMed ID: 32847674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
    Liu XY; Jiang YZ; Liu YR; Zuo WJ; Shao ZM
    Medicine (Baltimore); 2015 Aug; 94(31):e1309. PubMed ID: 26252312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
    Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
    Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant radiation therapy and survival for pure tubular breast carcinoma--experience from the SEER database.
    Li B; Chen M; Nori D; Chao KS; Chen AM; Chen SL
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):23-9. PubMed ID: 22543207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study.
    O'Malley CD; Le GM; Glaser SL; Shema SJ; West DW
    Cancer; 2003 Mar; 97(5):1303-11. PubMed ID: 12599239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database.
    Zhang N; Zhang H; Chen T; Yang Q
    Oncotarget; 2017 Apr; 8(15):24579-24592. PubMed ID: 28445946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors of diabetes and cancer-specific mortalities in patients with infiltrating ductal carcinoma of the breast: a population-based study.
    Elshanbary AA; Zaazouee MS; Nourelden AZ; Al-Kafarna M; Matar SG; Elsaeidy AS; Ragab KM; Elhady MM; Albadrani GM; Altyar AE; Kensara OA; Abdel-Daim MM
    Eur J Cancer Prev; 2024 Jul; 33(4):321-333. PubMed ID: 38190207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing lobular carcinoma of the male breast using the SEER database.
    Moten A; Obirieze A; Wilson LL
    J Surg Res; 2013 Dec; 185(2):e71-6. PubMed ID: 24071024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of socioeconomic status on survival for patients with anal cancer.
    Lin D; Gold HT; Schreiber D; Leichman LP; Sherman SE; Becker DJ
    Cancer; 2018 Apr; 124(8):1791-1797. PubMed ID: 29527660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.